Skip to main content
. 2021 Dec 16;13:1251–1260. doi: 10.2147/IJWH.S335977

Table 1.

Baseline Characteristics of the Study Groups

Variables Intervention Group Control Group
n=34 n=32
Maternal age (years) 31.4 (3.9) 30.8 (4.8)
Education
 Primary School 3 (9) 3 (9)
 High School 8 (23) 6 (19)
 University 18 (53) 16 (50)
 Other 5 (15) 7 (22)
Nulliparous women 13 (38) 12 (38)
Gestational age (week) 22.6 (5.5) 21.9 (5.2)
BMI at inclusion 27.1 (3.7) 26.2 (4.3)
Use of analgesics* 9 (26) 6 (19)
Pain provocation tests for anterior pain
Modified Trendelenburg test 24 (71) 20 (63)
MAT-test 24 (71) 26 (81)
Pain provocation tests for posterior pain
Modified Trendelenburg test 27 (79) 24 (75)
PPPP-test 33 (97) 28 (88)
Patrick’s Faber test 28 (82) 27 (84)
Functional test
ASLR- test (0–10) 4.9 (3.1) 4.3 (3.2)
Primary outcomes
Nightly anterior pain, VAS, 0–100 mm 44.3 (26.1) 46.5 (25.4)
Nightly posterior pain, VAS 61.2 (16.9) 60.4 (21.5)
Secondary outcomes
Evening anterior pain, VAS 45.9 (27.3) 51.2 (26.9)
Evening posterior pain, VAS 60.9 (17.6) 65.0 (20.9)
ESS 12.0 [7;16] 10.5 [8;13]
EQ-VAS 50.0 [30;60] 46.5 [34;65]
Nightly wake ups 3.9 (2.1) 3.2 (1.6)
PCS, total score 24.5 [17;34] 28.0 [19;36]
PGQ 52.5 [47;58] 49.0 [42;57]
Sleep duration, minutes 360 (85.2) 359 (78.0)
Women on sick leave 16 (47%) 15 (47)

Notes: Values are given as n (%), mean (SD) or median [25 to 75 quartiles] when appropriate. All p-values not significant. *Paracetamol. Intervention group, Standard treatment plus mattress and pillow, Control group, Standard treatment.

Abbreviations: ASLR-test, active straight leg test; BMI, body mass index; ESS, Epworth sleepiness scale; EQ-VAS, euroqol visual analogue scale; PGQ, pelvic girdle questionnaire; PCS, pain catastrophizing scale; PPPP-test, posterior pelvic pain provocation test; VAS, visual analogue scale: 0 to 100 mm.